pacritinib
cti biopharma
['pacritinib', 'ctibio', 'cti bio']
at #ash22, we presented new #anemia benefit data from our pacritinib program. cti is proud of our dedication to patients with #bloodcancers and our efforts to change the treatment paradigm. read the press release: 
Developing novel therapies for patients with rare blood-related cancers by uncovering the underlying scientific drivers of their disease